Basic Information
| RNALocate ID: | RLID-D:11000685 |
| RNA Symbol: | hsa-miR-500a-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-500a-5p |
| RNA ID: | miRBase:MIMAT0004773 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002664 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002665 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003982 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11003983 | Exosome | Plasma | 23663360 |
| RLID:11003984 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11001555 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-500a-5p | Medulloblastoma | MNDR-E-MI-55312 |
| MNDR | hsa-miR-500a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-55313 |
| MNDR | hsa-miR-500a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-55314 |
| MNDR | hsa-miR-500a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-55315 |
| MNDR | hsa-miR-500a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-55316 |
| MNDR | hsa-miR-500a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-55317 |
| MNDR | hsa-miR-500a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-55318 |
| MNDR | hsa-miR-500a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-55319 |
| MNDR | hsa-miR-500a-5p | Lupus nephritis | MNDR-E-MI-55320 |
| MNDR | hsa-miR-500a-5p | Prostate cancer | MNDR-E-MI-55321 |
| MNDR | hsa-miR-500a-5p | Gastric cancer | MNDR-E-MI-55322 |
| MNDR | hsa-miR-500a-5p | Alzheimer disease | MNDR-E-MI-55323 |
| MNDR | hsa-miR-500a-5p | Dysautonomia familial | MNDR-E-MI-55324 |
| MNDR | hsa-miR-500a-5p | Seizures | MNDR-E-MI-55325 |
| MNDR | hsa-miR-500a-5p | Leukemia | MNDR-E-MI-55326 |
| MNDR | hsa-miR-500a-5p | Friedreich ataxia | MNDR-E-MI-55327 |
| MNDR | hsa-miR-500a-5p | Lung cancer | MNDR-E-MI-55328 |
| MNDR | hsa-miR-500a-5p | Down syndrome | MNDR-E-MI-55329 |
| MNDR | hsa-miR-500a-5p | Parkinson disease | MNDR-E-MI-55330 |
| MNDR | hsa-miR-500a-5p | Breast cancer | MNDR-E-MI-55331 |
| MNDR | hsa-miR-500a-5p | Pancreatic cancer | MNDR-E-MI-55332 |
| MNDR | hsa-miR-500a-5p | Melanoma | MNDR-E-MI-55333 |
| MNDR | hsa-miR-500a-5p | Nephroblastoma | MNDR-E-MI-55334 |
| MNDR | hsa-miR-500a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-55335 |
| MNDR | hsa-miR-500a-5p | Familial ovarian cancer | MNDR-E-MI-55336 |
| MNDR | hsa-miR-500a-5p | Prostate adenocarcinoma | MNDR-E-MI-55337 |
| MNDR | hsa-miR-500a-5p | Carcinoma ductal breast | MNDR-E-MI-55338 |
| MNDR | hsa-miR-500a-5p | Glioblastoma | MNDR-E-MI-55339 |
| MNDR | hsa-miR-500a-5p | Glioma | MNDR-E-MI-55340 |
| MNDR | hsa-miR-500a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-55341 |
| MNDR | hsa-miR-500a-5p | Liposarcoma | MNDR-E-MI-55342 |
| MNDR | hsa-miR-500a-5p | Gastric adenocarcinoma | MNDR-E-MI-55343 |
| MNDR | hsa-miR-500a-5p | Lung squamous cell carcinoma | MNDR-E-MI-55344 |
| MNDR | hsa-miR-500a-5p | Lung adenocarcinoma | MNDR-E-MI-55345 |
| MNDR | hsa-miR-500a-5p | Adrenocortical carcinoma | MNDR-E-MI-55346 |
| MNDR | hsa-miR-500a-5p | Ovarian carcinoma | MNDR-E-MI-55347 |
| MNDR | hsa-miR-500a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-55348 |
| MNDR | hsa-miR-500a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-55349 |
| MNDR | hsa-miR-500a-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-55350 |
| MNDR | hsa-miR-500a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-55351 |
| MNDR | hsa-miR-500a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-55352 |
| MNDR | hsa-miR-500a-5p | Cholangiocarcinoma | MNDR-E-MI-55353 |
| MNDR | hsa-miR-500a-5p | Stomach carcinoma | MNDR-E-MI-55354 |
| MNDR | hsa-miR-500a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-55355 |
| MNDR | hsa-miR-500a-5p | Acute t cell leukemia | MNDR-E-MI-55356 |
| MNDR | hsa-miR-500a-5p | Breast invasive carcinoma | MNDR-E-MI-55357 |
| MNDR | hsa-miR-500a-5p | Hepatocellular carcinoma | MNDR-E-MI-55358 |
| MNDR | hsa-miR-500a-5p | Familiar ovarian carcinoma | MNDR-E-MI-55359 |
| MNDR | hsa-miR-500a-5p | Retinoblastoma | MNDR-E-MI-55360 |
| MNDR | hsa-miR-500a-5p | Tonsil cancer | MNDR-E-MI-55361 |
| MNDR | hsa-miR-500a-5p | Neuromyelitis optica | MNDR-E-MI-55362 |
| MNDR | hsa-miR-500a-5p | Colorectal cancer | MNDR-E-MI-55363 |
| MNDR | hsa-miR-500a-5p | Nasopharynx carcinoma | MNDR-E-MI-55364 |
| MNDR | hsa-miR-500a-5p | Multiple myeloma | MNDR-E-MI-55365 |
| MNDR | hsa-miR-500a-5p | Nasopharyngeal cancer | MNDR-E-MI-55366 |
| MNDR | hsa-miR-500a-5p | Gait ataxia | MNDR-E-MI-55367 |
| MNDR | hsa-miR-500a-5p | Stroke lacunar | MNDR-E-MI-55368 |
| MNDR | hsa-miR-500a-5p | Breast cancer her3+ negative | MNDR-E-MI-55369 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CYLD | Homo sapiens | RR00385277 |
TOP